These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia. Aleskog A; Tobin G; Laurell A; Thunberg U; Lindhagen E; Roos G; Nilsson K; Nygren P; Sundström C; Höglund M; Larsson R; Rosenquist R Eur J Haematol; 2004 Dec; 73(6):407-11. PubMed ID: 15522062 [TBL] [Abstract][Full Text] [Related]
23. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031 [TBL] [Abstract][Full Text] [Related]
24. The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Oppezzo P; Vasconcelos Y; Settegrana C; Jeannel D; Vuillier F; Legarff-Tavernier M; Kimura EY; Bechet S; Dumas G; Brissard M; Merle-Béral H; Yamamoto M; Dighiero G; Davi F; Blood; 2005 Jul; 106(2):650-7. PubMed ID: 15802535 [TBL] [Abstract][Full Text] [Related]
25. The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia. Francis S; Karanth M; Pratt G; Starczynski J; Hooper L; Fegan C; Pepper C; Valcarcel D; Milligan DW; Delgado J Cancer; 2006 Sep; 107(5):1023-33. PubMed ID: 16862572 [TBL] [Abstract][Full Text] [Related]
27. [Overrepresentation of specific gene segments of expressed immunoglobulin heavy chain variable region among unmutated and mutated patients with chronic lymphocytic leukemia]. Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Qi JY; Li CH; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):529-32. PubMed ID: 22338175 [TBL] [Abstract][Full Text] [Related]
28. The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia. Kipps TJ Best Pract Res Clin Haematol; 2007 Sep; 20(3):415-24. PubMed ID: 17707830 [TBL] [Abstract][Full Text] [Related]
29. What do somatic hypermutation and class switch recombination teach us about chronic lymphocytic leukaemia pathogenesis? Oppezzo P; Dighiero G Curr Top Microbiol Immunol; 2005; 294():71-89. PubMed ID: 16323428 [TBL] [Abstract][Full Text] [Related]
30. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia. Buhl AM; Jurlander J; Geisler CH; Pedersen LB; Andersen MK; Josefsson P; Petersen JH; Leffers H Eur J Haematol; 2006 Jun; 76(6):455-64. PubMed ID: 16529606 [TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of flow cytometric techniques in assessment of ZAP-70 expression in relation to IgVH mutational status in chronic lymphocytic leukemia. Chen YH; Peterson LC; Dittmann D; Evens A; Rosen S; Khoong A; Shankey TV; Forman M; Gupta R; Goolsby CL Am J Clin Pathol; 2007 Feb; 127(2):182-91. PubMed ID: 17210531 [TBL] [Abstract][Full Text] [Related]
32. [Clonality analysis and mutation status of IgVH genes in classic Richter's syndrome]. Mao ZR; Rosenwald A; Zhang SJ; Zhou R; Mueller-Hermelink HK Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):364-70. PubMed ID: 19031714 [TBL] [Abstract][Full Text] [Related]
33. Different clonal origin of B-cell populations of chronic lymphocytic leukemia and large-cell lymphoma in Richter's syndrome. Matolcsy A; Casali P; Knowles DM Ann N Y Acad Sci; 1995 Sep; 764():496-503. PubMed ID: 7486574 [TBL] [Abstract][Full Text] [Related]
34. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method. Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC; Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290 [TBL] [Abstract][Full Text] [Related]
36. Variations in the detection of ZAP-70 in chronic lymphocytic leukemia: Comparison with IgV(H) mutation analysis. Sheikholeslami MR; Jilani I; Keating M; Uyeji J; Chen K; Kantarjian H; O'Brien S; Giles F; Albitar M Cytometry B Clin Cytom; 2006 Jul; 70(4):270-5. PubMed ID: 16906585 [TBL] [Abstract][Full Text] [Related]
37. Prognostic value of immunoglobulin variable heavy chain gene mutation status: long term follow-up in a series of chronic lymphocytic leukemia patients. Panovska-Stavridis I; Cevreska L; Stojanovic A; Efremov D Prilozi; 2006 Dec; 27(2):127-37. PubMed ID: 17211297 [TBL] [Abstract][Full Text] [Related]
38. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. Calin GA; Ferracin M; Cimmino A; Di Leva G; Shimizu M; Wojcik SE; Iorio MV; Visone R; Sever NI; Fabbri M; Iuliano R; Palumbo T; Pichiorri F; Roldo C; Garzon R; Sevignani C; Rassenti L; Alder H; Volinia S; Liu CG; Kipps TJ; Negrini M; Croce CM N Engl J Med; 2005 Oct; 353(17):1793-801. PubMed ID: 16251535 [TBL] [Abstract][Full Text] [Related]
39. Bortezomib induces different apoptotic rates in B-CLL cells according to IgVH and BCL-6 mutations. Jantus-Lewintre E; Sarsotti E; Terol MJ; Benet I; García-Conde J Clin Transl Oncol; 2006 Nov; 8(11):805-11. PubMed ID: 17134969 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process. Letestu R; Rawstron A; Ghia P; Villamor N; Boeckx N; Boettcher S; Buhl AM; Duerig J; Ibbotson R; Kroeber A; Langerak A; Le Garff-Tavernier M; Mockridge I; Morilla A; Padmore R; Rassenti L; Ritgen M; Shehata M; Smolewski P; Staib P; Ticchioni M; Walker C; Ajchenbaum-Cymbalista F Cytometry B Clin Cytom; 2006 Jul; 70(4):309-14. PubMed ID: 16906588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]